Monday, September 7, 2026

No Result

View All Result

Media

No Result

View All Result

Health

Trump’s drug price push exposes Canada’s pricing flaws: John Adams and Nigel Rawson for Inside Policy

July 2, 2026

Nigel Rawson

Health

Hassling drug companies won’t aid ‘health emergency readiness’: Nigel Rawson and John Adams in the Financial Post

October 9, 2024

Health

To save lives, governments need to remove barriers to new medicines: Nigel Rawson and Barry Katsof in the Financial Post

September 3, 2024

Health

Waiting for a new medicine? Unfortunately, that’s government policy across Canada: Nigel Rawson and John Adams in the Hub

August 8, 2024

Health

Canadians needing new cancer drugs wait too long for government bureaucracy: Nigel Rawson in Saltwire

July 17, 2024

Inside Policy

Inside Policy: Activism or antisemitism?

July 10, 2024

Health

National pharmacare – might it be a pig in a poke? Nigel Rawson and John Adams for Inside Policy

May 28, 2024

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

Health

We should change how we evaluate cancer drugs: Nigel Rawson, Chak Balijepalli and David Stewart in the Financial Post

April 16, 2024

Columns

Why Canada spends so much on health care and still has a crisis: Nigel Rawson and John Adams in the Globe and Mail

March 6, 2024

Use COVID pause to reconsider drug-price regulation: Nigel Rawson and John Adams in the Financial Post

Columns

On this rarest of days, commit to support those with rare diseases: John Adams, Beth Vanstone and Nigel Rawson in the Financial Post

February 29, 2024

Past Events

Delayed and denied: The challenges faced by Canadians with rare disorders

January 16, 2024

Columns

Spend less on dental care and pharmacare, more on treatments for rare medical disorders: Nigel Rawson and John Adams in the Financial Post

January 4, 2024

When suicide attempts turn into assisted suicides: Alexander Raikin for Inside Policy

Columns

Government hostility to biopharmaceutical industry reduces access to innovative drugs: Nigel Rawson and John Adams in the Hill Times

November 16, 2023

Page 2 of 4 Prev 1 2 3 4 Next

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

No Result

View All Result

Trump’s drug price push exposes Canada’s pricing flaws: John Adams and Nigel Rawson for Inside Policy

Nigel Rawson

Hassling drug companies won’t aid ‘health emergency readiness’: Nigel Rawson and John Adams in the Financial Post

To save lives, governments need to remove barriers to new medicines: Nigel Rawson and Barry Katsof in the Financial Post

Waiting for a new medicine? Unfortunately, that’s government policy across Canada: Nigel Rawson and John Adams in the Hub

Canadians needing new cancer drugs wait too long for government bureaucracy: Nigel Rawson in Saltwire

Inside Policy: Activism or antisemitism?

National pharmacare – might it be a pig in a poke? Nigel Rawson and John Adams for Inside Policy

We should change how we evaluate cancer drugs: Nigel Rawson, Chak Balijepalli and David Stewart in the Financial Post

Why Canada spends so much on health care and still has a crisis: Nigel Rawson and John Adams in the Globe and Mail

On this rarest of days, commit to support those with rare diseases: John Adams, Beth Vanstone and Nigel Rawson in the Financial Post

Delayed and denied: The challenges faced by Canadians with rare disorders

Spend less on dental care and pharmacare, more on treatments for rare medical disorders: Nigel Rawson and John Adams in the Financial Post

Government hostility to biopharmaceutical industry reduces access to innovative drugs: Nigel Rawson and John Adams in the Hill Times

Top News

Don’t count on Europe to save us, Canada: Ed Fast and Richard Shimooka in The Hub

Geography trumps geopolitics — Canada cannot play Beijing off Washington: Khanh Vu Duc in the Western Standard

How diversity requirements reduced productivity for Canada’s research chairs: Peter Copeland and Eric Kaufmann on Inside Policy Talks

Multimedia

Judicializing Everything?: Mark Harding on Runnymede Radio

Deterrence is cheaper than defence: Christopher Coates and Lt.-Col. Joel Maley on Inside Policy Talks

Iran’s demands to reopen Strait of Hormuz includes unfreezing assets, compensation, more: Joe Varner on CTV News

The equity excellence trade-off: A study of EDI in the Canada Research Chairs Program

China is weaponizing the Canada–US trade rift to divide North America: Stephen Nagy for Inside Policy

U.S. trade deal dead until Canada stops being the ‘Ugly Ally’: Stephen Nagy in the National Post

Eric Kaufmann responds to allegations MLI paper is “racist and sexist”

Gruesome beheading attempt in Belfast a warning against fast-track asylum processes: Michael Barutciski in the National Post

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

Support Us